AAMC
RMD icon

Asset Allocation & Management Company’s ResMed RMD Stock Holding History

Asset Allocation & Management Company’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-820
Closed -$212K – 94
2025
Q2 		$212K Buy
+820
New +$196K 0.1% 87

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

Asset Allocation & Management Company's RMD Position: Q3 2025 in Review

Asset Allocation & Management Company sold out of ResMed (RMD) in Q3 2025, closing a stake of 820 shares — an estimated $212K sold.

Asset Allocation & Management Company first reported a position in RMD in Q2 2025 and held it in 1 quarter. The position peaked at $212K in Q2 2025. 950 funds tracked by Wall St. Rank hold RMD as of Q3 2025.

  • Asset Allocation & Management Company reported no remaining ResMed position as of Q3 2025 after selling out during the quarter.
  • Asset Allocation & Management Company sold 820 ResMed shares in Q3 2025, an estimated $212K.
  • Asset Allocation & Management Company first reported a position in ResMed in Q2 2025 and held it in 1 quarter.
  • Asset Allocation & Management Company's ResMed position peaked at $212K in Q2 2025.
  • 950 funds tracked by Wall St. Rank held ResMed as of Q3 2025.

Based on Asset Allocation & Management Company's 13F filing for Q3 2025, filed 3 Nov 2025.